Effects of Highly Absorptive Curcumin on Inflammation in Chronic Obstructive Pulmonary Disease (HS-Cur COPD study)
Not Applicable
Completed
- Conditions
- Mild or moderate chronic obstructive pulmonary disease
- Registration Number
- JPRN-UMIN000009139
- Lead Sponsor
- ational Hospital Organization Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) severe lung diseases other than COPD 2) renal insufficiency (Cre >= 4.0mg/dL) or hemodialysis 3) severe hepatic disorder or liver cirrhosis 4) Unstable angina pectoris, acute myocardial infarction, severe coronary heart disease (left main trunk or triple vessel disease) 5) Shock, Heart failure, myocardial infarction, Pulmonary embolism 6) Stroke within 3 months 7) Uncontrolled diabetes (more than 10% of HbA1c) 8) Severe infection or trauma 9) Malnutrition 10) Malignancy 11) Anemia (less than 6 mg/dL of Hb) 12) Use of steroid or antibiotics 13) Intake of curcumin 14) Allergy 15) Pregnancy 16) etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of inflammatory biomarkers such as IL-6, hsCRP, SAA-LD
- Secondary Outcome Measures
Name Time Method